Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Deep brain stimulation].

V Fraix1, P Pollak, S Chabardes

  • 1Département de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble. Valerie.Fraix@ujf-grenoble.fr

Revue Neurologique
|July 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital speech biomarkers can measure acute effects of levodopa in Parkinson's disease.

NPJ Parkinson's disease·2025
Same author

Improvement of apathy in early Parkinson's disease.

NPJ Parkinson's disease·2025
Same author

Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale.

Revue neurologique·2024
Same author

Late adult-onset Niemann Pick type C (NPC): An "atypical" typical presentation at the age of 62.

Parkinsonism & related disorders·2023
Same author

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD.

NPJ Parkinson's disease·2020
Same author

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Parkinsonism & related disorders·2019
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Deep brain stimulation (DBS) offers renewed hope for Parkinson's disease patients by targeting basal ganglia pathways. Subthalamic nucleus stimulation shows promise for improving motor symptoms and reducing medication needs.

Area of Science:

  • Neurosurgery
  • Neurology
  • Neuroscience

Context:

  • Parkinson's disease (PD) surgical treatments were largely abandoned but are reviving due to improved understanding of basal ganglia function.
  • Advances in stereotactic neurosurgery, neuroimaging, and electrophysiology enhance deep brain target localization.

Purpose:

  • To review the resurgence of surgical interventions for Parkinson's disease, focusing on deep brain stimulation (DBS).
  • To discuss the underlying pathophysiology of Parkinson's disease and the mechanisms of DBS.
  • To evaluate different DBS targets and their efficacy in treating Parkinson's disease symptoms.

Summary:

  • DBS efficacy stems from understanding dopaminergic neuron loss in Parkinson's disease, leading to overactivity in the subthalamo-internal pallidum pathway.

Related Experiment Videos

  • High-frequency stimulation of the thalamus (VIM) and subthalamic nucleus (STN) are key techniques, with STN stimulation showing significant benefits for motor symptoms and dyskinesia.
  • Patient selection criteria include good general health, absence of severe depression or dementia, and responsiveness to levodopa.

    • Impact:

    • Deep brain stimulation, particularly STN stimulation, offers a viable treatment for severely disabled Parkinson's patients, reducing medication dependence and improving motor function.
    • Further randomized controlled trials are needed to compare different DBS targets and techniques, including cost-benefit analyses.
    • This neurosurgical approach represents a significant advancement in managing Parkinson's disease, offering symptomatic relief and improved quality of life.